GO	[-23.88 -0.93]	[-0.93 -0.52]	[-0.52 -0.27]	[-0.27 -0.18]	[-0.18 0.00]	[0.00 0.00]	[0.00 0.22]	[0.22 0.56]	[0.56 1.22]	[1.22 2.16]	[2.16 10.00]
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	-1.680	-5.482	-5.482	-3.375	-0.728	9.550	-1.386	-1.132	-0.335	2.507	8.538
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-1.996	-2.384	-1.996	-1.658	-1.996	-1.658	-3.937	0.479	1.992	1.992	18.266
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.692	-1.123	-2.116	-2.116	-3.100	-3.729	-3.100	0.310	1.730	6.106	10.902
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.675	-4.888	-2.412	-1.341	-2.891	-1.081	-2.891	-0.395	3.116	6.292	8.779
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	-0.873	-4.301	-4.301	1.065	-0.551	9.782	-3.147	-3.147	-0.873	2.454	3.707
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	-1.474	-1.173	-4.084	-0.712	-2.255	-2.255	-2.758	0.708	1.081	3.777	12.064
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.981	-0.473	-3.526	-1.868	-0.981	-3.526	-1.868	0.435	1.082	2.827	9.847
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	1.089	-2.064	-1.359	-3.662	-3.662	-2.511	-1.359	0.571	2.993	2.665	6.259
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.270	-1.680	-2.410	-1.386	-3.375	-0.728	-1.386	-0.728	0.468	4.911	10.656
WU_CELL_MIGRATION WU_CELL_MIGRATION	-1.924	-5.333	-3.252	0.301	-1.593	-0.524	-0.401	-0.524	2.083	5.130	5.144
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.687	-3.283	-2.774	-1.948	-2.332	-1.326	-0.687	0.950	3.927	2.324	6.368
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-1.837	-1.837	-1.528	-1.528	-1.259	-3.060	-1.259	0.636	4.550	2.555	6.623
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	0.636	-4.910	-4.910	2.275	-0.517	2.012	-0.659	-3.060	-0.828	3.826	2.021
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.104	-2.623	-1.044	-1.044	-1.548	-3.089	-2.216	0.496	0.926	1.299	9.969
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.400	-2.071	-1.635	-2.071	-2.604	-0.982	-2.071	0.594	1.440	4.691	6.157
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-2.011	-2.454	-2.011	-2.454	-0.822	-2.011	-0.482	1.133	3.804	1.851	5.928
NABA_ECM_AFFILIATED NABA_ECM_AFFILIATED	-0.385	-1.975	-3.418	-0.285	-1.975	0.318	-1.063	-1.623	0.423	3.863	8.337
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-1.392	-1.765	-0.331	-2.217	-0.625	-3.439	-1.765	0.519	3.160	2.130	5.777
NABA_ECM_GLYCOPROTEINS NABA_ECM_GLYCOPROTEINS	-0.408	-1.548	-3.622	0.496	-0.528	0.386	-2.216	-1.278	-0.528	2.244	9.445
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-0.326	-2.830	-1.996	-2.384	-0.714	-1.658	-1.366	0.479	2.542	3.835	4.980
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	-1.221	-1.511	-4.667	0.268	-0.767	-0.452	-1.511	-0.767	1.354	4.504	5.352
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	-0.582	-1.055	-2.287	0.439	-0.582	0.593	-1.382	-3.713	-0.792	3.986	6.449
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	0.632	-2.881	-2.881	-2.163	-0.875	-1.201	-0.432	-0.290	1.351	1.351	7.390
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.474	-5.857	-3.147	-0.873	-0.698	-0.698	-0.698	0.474	1.463	3.694	3.707
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.391	-1.153	-0.903	-3.325	-0.903	-4.947	-0.528	2.420	2.116	2.744	2.124
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	0.470	-2.636	-2.144	-1.093	-1.731	-0.258	-0.851	-1.093	0.777	2.224	8.299
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	-2.335	-0.903	-0.903	-0.687	-0.687	-3.581	-1.486	1.194	2.969	0.782	5.974
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	0.652	-1.592	-2.844	-0.854	-0.606	-1.176	-1.176	-1.176	1.385	0.864	8.798
GAURNIER_PSMD4_TARGETS GAURNIER_PSMD4_TARGETS	-0.986	-2.944	-2.034	-0.668	-1.424	0.712	-0.668	-0.986	0.500	4.323	4.900
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-1.011	-1.011	-1.507	-0.506	-1.011	-4.874	-0.646	0.309	3.199	2.042	5.001
NAKAJIMA_EOSINOPHIL NAKAJIMA_EOSINOPHIL	-1.036	-1.036	-1.036	-1.036	-0.222	-1.036	-1.036	0.726	-0.491	0.398	9.520
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-1.326	-0.363	-1.326	-1.326	-1.326	-1.326	0.247	-0.363	0.480	0.794	8.532
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	-0.411	-1.906	-0.702	-1.157	-0.411	-1.906	-0.228	-1.157	-0.228	1.271	9.138
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	0.772	-3.235	-1.643	-0.559	-1.171	0.381	-2.289	-1.171	1.025	3.269	3.763
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.280	-0.365	-0.486	-1.925	-0.269	-6.983	0.574	0.889	3.244	0.336	2.603
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	0.392	-1.691	-4.175	-0.703	-0.893	-0.310	-1.117	-1.117	0.976	3.721	5.301
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-1.362	-1.362	-0.864	-0.864	-0.864	-1.362	-2.155	-0.316	2.203	3.220	4.409
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	0.326	-3.401	-1.771	-0.633	-0.911	-0.277	-1.280	-0.633	0.326	2.578	6.812
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-0.771	-1.051	-1.858	-4.233	-1.051	-1.051	-0.260	1.665	3.983	0.667	2.717
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.310	-2.627	-0.922	-2.169	-1.162	-1.445	-0.922	0.292	1.933	2.511	5.988
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	-0.865	-2.362	-1.225	-0.397	-1.707	-0.397	-0.865	-0.397	-0.397	4.109	6.401
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-1.201	-1.489	-1.201	-0.752	-0.752	-3.227	-1.489	1.162	4.163	2.748	2.153
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	-0.537	-0.537	-5.191	-0.727	-2.042	-0.727	0.331	0.458	2.045	0.610	5.239
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.353	-2.577	-0.959	-0.959	-1.465	-0.959	-0.595	0.261	-0.457	1.746	9.343
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.636	-1.259	-2.596	-1.528	0.396	-2.191	-1.837	-0.517	2.849	1.765	4.564
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	-0.331	0.384	-2.217	-0.830	-1.765	-2.765	-1.392	-0.461	2.130	4.375	2.804
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	1.264	-1.806	-0.975	-0.975	-1.211	-2.605	-0.975	-0.262	0.721	0.721	8.220
REACTOME_INTERLEUKIN_10_SIGNALING REACTOME_INTERLEUKIN_10_SIGNALING	-0.676	-1.124	-1.124	-0.676	-1.865	0.226	-1.124	-0.392	0.226	0.958	9.348
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	0.560	-0.648	-4.815	-0.648	-1.045	-1.600	-0.498	-0.648	0.871	3.912	3.924
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	3.080	-2.454	-1.317	-1.636	-1.317	-1.317	-0.822	-0.822	0.934	2.745	3.444
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	-0.810	-1.783	-1.211	-1.211	-1.211	-0.329	-0.527	-0.810	0.275	3.302	6.980
TOMLINS_PROSTATE_CANCER_DN TOMLINS_PROSTATE_CANCER_DN	-0.958	-1.658	-1.658	-0.958	0.820	-0.958	-0.958	-0.300	3.814	-0.549	4.501
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	-2.253	-2.253	-1.611	-0.797	-0.354	-0.797	-0.797	0.798	2.875	4.914
REACTOME_ECM_PROTEOGLYCANS REACTOME_ECM_PROTEOGLYCANS	1.724	-1.580	-1.580	-1.580	-2.216	0.265	-1.117	-0.775	2.096	0.599	4.447
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	-0.285	-0.385	-2.385	-0.845	-1.320	-1.063	-0.661	-0.661	1.035	0.423	9.401
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-0.392	-1.287	0.409	-1.900	-1.571	-4.488	0.409	3.664	1.177	0.309	2.695
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-0.913	-1.132	0.360	-0.913	-1.386	-3.970	-1.132	1.271	1.271	1.484	4.926
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	-0.645	-1.536	-1.536	-0.235	-0.645	3.340	-1.536	-1.006	-0.645	0.379	5.798
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	0.310	0.554	-2.255	-2.758	-2.255	-1.831	-0.541	2.382	1.800	0.554	3.052
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	-1.439	-1.439	-2.276	0.361	-1.818	-0.866	0.255	-0.486	0.643	3.838	4.703
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	-1.093	-1.384	-2.636	-0.652	-0.851	-1.384	-0.851	1.404	2.872	0.612	4.836
WP_VITAMIN_D_RECEPTOR_PATHWAY WP_VITAMIN_D_RECEPTOR_PATHWAY	-1.096	-0.882	-1.972	-2.802	-0.882	2.577	-1.346	0.620	-0.318	3.198	2.890
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	-0.538	-1.998	-2.695	-0.771	-1.077	0.246	0.246	-1.077	1.528	1.528	5.515
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.430	-2.006	-1.273	-0.580	-0.996	-2.006	-1.273	0.872	2.414	0.693	5.617
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	-1.858	-1.051	-0.552	-0.385	-3.182	-0.771	-0.771	0.667	2.709	0.492	4.964
LEE_EARLY_T_LYMPHOCYTE_DN LEE_EARLY_T_LYMPHOCYTE_DN	-0.668	-0.668	-1.035	-2.404	-1.571	-1.571	-0.247	-0.247	1.845	2.747	3.264
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	-0.338	-1.420	-1.933	-1.029	-0.338	-2.621	-0.505	5.126	1.023	-0.338	2.319
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.661	-1.668	-2.921	-0.405	-2.439	-0.301	-1.361	-0.301	1.406	3.768	2.457
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.552	-1.276	-2.604	-0.552	-0.552	-3.262	-0.552	0.768	2.008	3.031	2.334
WP_SPINAL_CORD_INJURY WP_SPINAL_CORD_INJURY	-0.629	-1.871	-3.016	-1.457	0.281	-1.120	0.281	-0.322	0.914	3.806	3.401
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	0.784	-2.446	-1.064	-0.691	-1.606	0.346	-0.434	-0.434	-1.064	1.791	5.555
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.357	-1.962	-2.861	-0.252	-1.362	-0.626	-0.626	-0.252	0.539	1.336	5.712
KEGG_ECM_RECEPTOR_INTERACTION KEGG_ECM_RECEPTOR_INTERACTION	0.451	-1.335	-1.335	-1.335	0.301	-0.671	-2.510	-0.671	1.726	0.636	5.988
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	0.292	-2.484	-1.273	0.292	-0.996	-1.607	-0.430	-1.607	2.414	1.814	4.279
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.745	-0.745	-0.745	-0.298	-0.745	-0.298	-0.745	0.304	0.304	-0.745	8.475
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.240	-0.606	-1.926	-1.332	-1.332	-0.606	-0.606	0.790	-0.606	0.790	7.866
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.595	-1.707	-0.865	-1.225	-1.225	-2.362	-0.595	0.724	1.902	3.608	2.288
DELPUECH_FOXO3_TARGETS_UP DELPUECH_FOXO3_TARGETS_UP	-1.241	-0.835	-1.241	-0.546	-1.819	-1.819	-0.835	1.168	0.876	3.226	3.233
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-0.889	-1.567	0.280	-1.190	-1.190	-1.190	-1.190	-0.323	0.741	2.072	6.602
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.718	-1.209	-3.652	1.145	-1.925	0.933	-1.209	-0.539	0.580	3.240	2.222
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	-0.311	-0.996	-4.637	-0.580	-0.996	0.872	-0.996	-0.311	0.536	1.298	5.153
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-1.181	-2.612	-1.181	-0.508	-0.508	-1.181	-1.181	0.938	1.593	1.982	3.388
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-0.477	0.257	-1.361	-2.116	-1.361	-2.116	-0.834	0.257	2.261	2.915	3.282
WP_PEPTIDE_GPCRS WP_PEPTIDE_GPCRS	0.428	-2.180	-1.548	0.850	0.276	1.769	-1.091	-3.111	-0.753	1.769	2.153
REACTOME_L1CAM_INTERACTIONS REACTOME_L1CAM_INTERACTIONS	-0.661	-1.507	-0.661	-0.343	-0.482	-5.024	0.515	0.263	3.285	0.515	2.548
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	0.849	-2.476	-1.956	0.254	-1.532	-1.956	0.364	0.364	0.364	1.062	5.456
VILIMAS_NOTCH1_TARGETS_UP VILIMAS_NOTCH1_TARGETS_UP	-0.301	-1.328	-1.328	-1.328	-2.114	-0.301	-0.837	0.750	0.301	2.270	4.519
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	0.283	-0.640	-1.243	-0.640	-1.243	-1.243	-1.243	-0.320	0.539	2.991	3.690
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.815	-1.900	-1.571	-0.836	-1.044	-1.044	-2.280	0.309	2.114	2.391	3.333
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-2.089	-3.158	-2.089	-0.340	-0.623	-0.465	-0.465	0.814	2.298	1.998	2.628
WP_HUMAN_COMPLEMENT_SYSTEM WP_HUMAN_COMPLEMENT_SYSTEM	0.259	-3.069	-1.768	0.384	-1.768	0.384	-0.506	0.384	-0.348	0.728	6.296
SCHOEN_NFKB_SIGNALING SCHOEN_NFKB_SIGNALING	-1.409	-1.409	-1.409	-0.765	-0.765	0.716	-0.407	0.216	0.216	0.716	6.224
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-1.167	-1.871	-0.512	-0.373	-1.486	-1.167	0.464	-1.167	0.464	3.728	4.577
STEARMAN_TUMOR_FIELD_EFFECT_UP STEARMAN_TUMOR_FIELD_EFFECT_UP	-0.477	-1.533	-0.860	-0.860	-0.860	-1.533	-0.250	-0.860	2.304	1.788	3.509
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.438	-0.986	-0.668	-1.424	-0.986	-2.944	-0.668	1.260	1.260	0.966	4.332
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	-0.527	-1.211	0.275	-0.810	-2.654	-0.527	-1.211	0.651	-0.527	2.808	4.404
REACTOME_MUSCLE_CONTRACTION REACTOME_MUSCLE_CONTRACTION	-1.278	-3.089	-2.623	0.293	0.293	-0.672	-0.843	0.386	1.739	2.813	2.823
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	-2.399	-0.266	-0.888	-1.252	-0.888	-2.399	-0.266	3.537	0.701	0.701	2.642
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	1.320	-1.865	-0.392	-1.124	-0.392	-1.124	-1.124	-1.124	0.958	0.409	5.258
LEE_LIVER_CANCER_ACOX1_UP LEE_LIVER_CANCER_ACOX1_UP	-0.835	-1.819	-0.344	-1.819	0.876	-0.546	-2.695	0.262	0.876	2.740	2.295
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	0.492	-0.552	-1.051	0.346	-1.858	-4.233	-0.771	0.492	1.108	1.372	3.117
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	0.321	-2.071	-1.635	-0.400	-0.982	-1.635	-0.982	-0.282	1.712	1.712	4.703
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	0.876	-2.695	-1.819	-1.241	-0.835	-0.546	-0.546	0.262	1.168	0.876	4.310
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	0.467	-3.443	-0.934	-1.308	-1.308	-0.934	-0.442	2.130	1.768	0.657	2.136
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	1.309	-2.500	-1.918	-0.411	-0.809	1.054	-1.097	-0.809	-0.809	2.244	3.422
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	0.346	-1.606	-2.446	-0.691	-0.691	-0.434	-0.691	0.346	2.213	-0.434	4.910
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	0.577	-0.975	-1.486	0.344	-0.776	-1.806	-1.211	-1.211	5.415	0.577	2.251
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.457	-1.335	-1.335	-0.671	-1.335	-0.671	-0.957	0.636	0.857	0.451	7.227
PLASARI_TGFB1_TARGETS_1HR_UP PLASARI_TGFB1_TARGETS_1HR_UP	-1.367	-1.367	-0.385	-1.367	-0.733	-0.733	-0.733	1.130	0.453	3.306	2.096
BORCZUK_MALIGNANT_MESOTHELIOMA_DN BORCZUK_MALIGNANT_MESOTHELIOMA_DN	-0.617	-1.978	-1.513	0.433	-1.143	-1.143	-1.143	0.433	0.593	3.297	3.736
SANA_TNF_SIGNALING_UP SANA_TNF_SIGNALING_UP	0.636	-1.335	-0.457	-1.835	-0.957	-0.957	-1.335	-0.301	0.301	2.082	5.406
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	-0.943	-1.583	-2.540	-0.264	-1.231	0.342	0.342	-0.523	0.472	1.014	6.316
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	0.582	-0.886	-3.291	0.742	-0.886	-0.886	-1.133	-0.381	-0.515	2.459	4.295
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-0.786	-1.181	-0.508	-0.508	-0.508	-2.612	-1.181	0.288	0.938	2.878	3.388
LINDSTEDT_DENDRITIC_CELL_MATURATION_A LINDSTEDT_DENDRITIC_CELL_MATURATION_A	0.478	-2.571	-0.489	-1.712	-0.762	-0.762	-0.489	-0.301	0.478	1.284	5.214
KATSANOU_ELAVL1_TARGETS_UP KATSANOU_ELAVL1_TARGETS_UP	-0.310	-4.175	-1.382	-0.545	-0.703	-0.545	-0.310	-0.545	1.612	1.861	3.733
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	-0.640	-1.243	-1.243	-0.320	-0.640	-0.320	-1.243	0.881	-0.640	1.796	4.445
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	2.771	-1.055	-0.582	-1.382	-0.792	-1.382	-2.287	2.076	-0.417	0.439	2.780
DIRMEIER_LMP1_RESPONSE_EARLY DIRMEIER_LMP1_RESPONSE_EARLY	-0.762	-0.301	-1.712	-2.571	0.478	-1.712	-0.301	0.301	1.284	0.701	4.016
WP_ALLOGRAFT_REJECTION WP_ALLOGRAFT_REJECTION	-0.538	-1.998	-1.476	-0.538	-1.476	0.376	0.539	0.246	-1.077	4.432	2.609
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-1.009	-0.356	-0.798	-1.901	-0.356	-2.773	-1.009	0.457	2.330	2.951	2.054
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	-0.341	-1.284	-0.671	-0.671	-1.284	-1.284	0.509	-0.341	2.879	-0.341	3.558
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	2.495	-0.790	-4.383	-0.270	-0.621	-0.992	-0.992	-0.479	0.564	1.457	2.504
WP_COMPLEMENT_AND_COAGULATION_CASCADES WP_COMPLEMENT_AND_COAGULATION_CASCADES	0.346	-1.064	-2.446	-0.260	-0.691	-0.691	-0.691	-0.434	0.346	0.784	6.233
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-1.448	-1.053	-1.053	-1.448	-0.521	-1.966	0.256	0.557	2.656	1.566	2.663
REACTOME_LAMININ_INTERACTIONS REACTOME_LAMININ_INTERACTIONS	0.283	-0.640	-1.243	-1.243	-1.243	-0.640	-0.640	0.283	2.991	0.283	2.996
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	0.392	-2.050	-3.514	-0.703	-1.117	0.801	0.392	-0.703	1.169	1.381	3.044
VANHARANTA_UTERINE_FIBROID_DN VANHARANTA_UTERINE_FIBROID_DN	0.818	-1.890	-1.301	-1.890	-0.586	-1.301	-0.586	1.776	0.388	1.776	2.180
FRIDMAN_SENESCENCE_UP FRIDMAN_SENESCENCE_UP	-0.797	-0.354	-0.541	-1.611	-1.611	-0.797	0.397	-1.144	1.681	0.798	4.914
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	0.910	-1.466	-0.949	0.416	-0.949	1.232	-1.466	-0.949	-1.466	2.473	2.020
KEGG_CELL_ADHESION_MOLECULES_CAMS KEGG_CELL_ADHESION_MOLECULES_CAMS	0.384	-1.765	-1.765	-0.830	-0.625	-1.083	-0.625	0.384	0.273	3.950	3.169
WILENSKY_RESPONSE_TO_DARAPLADIB WILENSKY_RESPONSE_TO_DARAPLADIB	-0.279	-0.279	-0.580	-1.160	-0.580	-1.160	-1.160	-0.279	-0.279	3.235	3.240
KEGG_HEMATOPOIETIC_CELL_LINEAGE KEGG_HEMATOPOIETIC_CELL_LINEAGE	-1.868	-0.691	-1.363	0.435	-0.313	-0.473	-1.868	0.289	-0.313	2.827	3.744
REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	-0.586	-0.586	-1.890	0.388	-0.586	-1.301	-1.301	-0.374	0.388	3.584	3.086
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3 WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3	-0.364	-2.695	-1.476	-0.771	0.539	0.736	0.736	-1.476	-0.364	0.539	4.442
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	-0.434	-0.434	-1.064	-0.260	-0.691	-2.446	-0.691	-0.260	0.784	0.541	5.555
LEE_LIVER_CANCER_E2F1_UP LEE_LIVER_CANCER_E2F1_UP	0.288	-2.612	-0.786	-1.748	0.459	-0.508	-0.786	-0.508	1.244	1.982	2.417
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	0.353	-3.981	-1.558	-0.924	-0.693	-0.510	0.353	0.486	1.272	1.531	2.460
KEGG_AXON_GUIDANCE KEGG_AXON_GUIDANCE	0.291	-0.595	-1.345	-0.311	-0.595	-4.211	-0.436	1.615	1.615	-0.311	2.544
DORSEY_GAB2_TARGETS DORSEY_GAB2_TARGETS	-0.640	-1.243	-0.320	-0.640	-0.320	-0.320	-1.243	-0.320	-0.320	0.881	6.127
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-1.124	-1.865	-1.124	-0.676	0.654	-0.392	-1.124	0.409	0.409	1.320	3.905
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	0.539	-1.243	-1.243	-0.640	0.539	-1.243	-1.243	0.283	0.283	1.301	2.996
LU_TUMOR_ANGIOGENESIS_UP LU_TUMOR_ANGIOGENESIS_UP	-1.036	-1.036	-0.491	-0.491	0.726	-1.036	-1.036	-0.222	2.916	-0.222	2.253
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	-0.523	-1.580	-1.580	-0.775	-1.117	-1.117	0.599	-0.341	1.724	1.388	3.416
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	-0.336	-0.599	-1.740	0.269	-0.599	1.083	-1.024	-1.740	0.269	1.083	3.598
LEE_LIVER_CANCER_DENA_UP LEE_LIVER_CANCER_DENA_UP	-0.714	-1.093	-1.093	-1.641	-0.273	0.756	-1.641	-0.452	0.756	3.099	2.158
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	-0.712	-1.928	-1.611	0.463	-1.611	-0.888	-0.437	0.270	1.439	3.006	2.430
CROONQUIST_STROMAL_STIMULATION_UP CROONQUIST_STROMAL_STIMULATION_UP	0.397	-2.321	-1.501	-0.382	-0.977	-0.382	0.233	-0.382	1.191	0.233	4.606
REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	-0.266	-0.500	-1.575	0.584	-0.893	-0.500	-1.575	-0.266	-0.500	3.391	2.227
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	0.291	-1.098	-0.613	-0.443	-0.613	-1.098	-1.843	-0.829	0.735	4.765	2.005
DEMAGALHAES_AGING_UP DEMAGALHAES_AGING_UP	-1.431	-1.431	-0.578	0.435	-0.348	-0.920	-0.578	-1.431	1.652	1.652	3.059
WEINMANN_ADAPTATION_TO_HYPOXIA_DN WEINMANN_ADAPTATION_TO_HYPOXIA_DN	0.320	-1.616	0.320	0.858	-1.616	-0.283	-0.283	0.320	-1.616	-0.283	3.938
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	0.330	-1.093	-1.093	-0.714	-1.093	-0.273	-0.452	0.756	-0.452	-0.452	6.806
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	-0.348	-0.984	-1.768	-0.984	-0.348	-0.984	-0.506	-0.348	0.384	1.472	5.737
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	0.701	-1.152	-1.712	-0.762	0.301	0.301	-0.762	-1.712	0.970	0.301	4.598
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	-0.351	-1.053	-1.966	-0.751	-0.751	-0.751	-0.351	-0.351	0.256	4.006	3.086
LINDVALL_IMMORTALIZED_BY_TERT_UP LINDVALL_IMMORTALIZED_BY_TERT_UP	-0.586	0.581	-0.586	-0.884	-2.778	-1.301	0.238	0.581	1.416	-0.374	3.591
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	-0.447	-0.746	-1.760	-1.173	-1.173	-2.126	0.362	1.533	0.920	1.533	2.923
LIM_MAMMARY_LUMINAL_MATURE_DN LIM_MAMMARY_LUMINAL_MATURE_DN	1.616	-0.641	-2.197	-0.447	-1.650	-0.897	-1.226	1.052	-0.301	1.318	2.688
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	0.404	-2.621	-1.420	1.023	0.267	0.267	-0.505	-1.933	-0.338	1.297	3.148
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	0.263	-1.507	-0.885	-2.445	-1.164	-1.164	0.515	1.328	0.870	1.086	2.910
OSADA_ASCL1_TARGETS_DN OSADA_ASCL1_TARGETS_DN	-0.994	-0.994	-0.994	-0.994	-0.994	-0.204	-0.204	0.426	1.744	0.772	2.361
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	0.923	-2.129	-1.022	-1.687	-1.322	-0.581	0.420	-0.581	1.647	1.382	2.588
BHAT_ESR1_TARGETS_VIA_AKT1_DN BHAT_ESR1_TARGETS_VIA_AKT1_DN	-0.427	-1.280	-1.771	-0.427	-0.427	-1.771	-0.277	3.955	0.326	0.326	2.185
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	-1.415	-1.792	-0.848	-0.473	-1.415	-0.473	-0.341	2.750	1.044	0.264	3.120
BRUECKNER_TARGETS_OF_MIRLET7A3_DN BRUECKNER_TARGETS_OF_MIRLET7A3_DN	-0.775	-1.580	-0.523	-1.580	-1.117	-0.523	-0.523	1.087	2.501	0.412	2.946
BURTON_ADIPOGENESIS_PEAK_AT_2HR BURTON_ADIPOGENESIS_PEAK_AT_2HR	-0.702	-1.906	-0.702	-0.228	-0.411	-0.702	-0.702	0.625	-0.411	0.920	5.124
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	-0.365	-0.486	-2.330	0.445	-1.280	0.574	-2.330	-0.634	1.752	1.508	2.304
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	-0.285	-1.293	-0.492	-1.293	-0.809	-1.293	-0.809	0.317	2.847	1.095	2.344
CROMER_TUMORIGENESIS_UP CROMER_TUMORIGENESIS_UP	-0.416	-1.571	-1.571	0.362	-0.247	0.362	-1.571	-0.416	0.564	0.362	5.019
WOTTON_RUNX_TARGETS_DN WOTTON_RUNX_TARGETS_DN	0.302	-1.201	-0.610	0.572	-1.201	-1.201	-0.300	-0.300	-0.610	2.460	2.464
BYSTROEM_CORRELATED_WITH_IL5_UP BYSTROEM_CORRELATED_WITH_IL5_UP	-1.024	1.083	1.478	0.269	-0.599	-1.740	-0.599	-0.336	-1.740	0.476	2.437
REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	-0.324	0.279	2.204	-0.476	0.576	-2.264	0.997	-0.476	-1.709	-1.709	2.211
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	-0.525	-0.525	-0.525	-0.925	-1.616	-1.616	-0.283	0.858	0.555	1.656	2.693
WARTERS_IR_RESPONSE_5GY WARTERS_IR_RESPONSE_5GY	-2.031	0.334	-0.471	-2.031	-0.270	-1.259	0.546	0.546	0.546	0.546	2.935
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	-1.064	-1.517	-2.143	0.289	0.445	-1.517	-0.488	0.642	1.815	0.878	2.206
WP_LUNG_FIBROSIS WP_LUNG_FIBROSIS	-1.181	-1.181	-1.748	-0.315	-0.508	0.288	0.288	-0.315	0.288	0.459	5.744
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	-0.924	0.353	-1.558	-0.693	-1.985	-0.693	1.272	-0.693	0.828	0.644	4.006
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	-0.580	-0.580	-0.580	-1.160	0.324	-0.580	-0.580	-1.160	0.978	0.978	3.977
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	-0.473	-1.363	-1.363	-0.981	-0.981	-0.313	-0.691	0.289	1.684	0.831	4.241
KHETCHOUMIAN_TRIM24_TARGETS_UP KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.702	-0.411	-0.702	-0.702	-1.157	-1.906	0.389	-0.411	1.677	0.920	3.199
WIERENGA_STAT5A_TARGETS_GROUP2 WIERENGA_STAT5A_TARGETS_GROUP2	-0.578	-1.431	-0.920	-0.578	-0.578	-0.348	-0.920	0.258	-0.348	3.602	3.059
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.373	-0.805	-0.805	-0.634	-0.277	-4.418	0.326	0.326	1.220	1.663	2.186
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	-1.117	-1.580	-2.216	0.265	0.412	-1.117	-0.523	0.599	2.096	0.824	2.102
REACTOME_POTASSIUM_CHANNELS REACTOME_POTASSIUM_CHANNELS	-0.270	-0.790	-2.466	-0.398	-0.270	0.476	-1.888	-0.790	0.849	1.629	3.062
HINATA_NFKB_TARGETS_KERATINOCYTE_UP HINATA_NFKB_TARGETS_KERATINOCYTE_UP	-0.691	-0.691	-0.981	-0.473	-1.363	-0.313	-1.363	-0.473	2.034	1.082	3.744
REACTOME_DISEASES_OF_GLYCOSYLATION REACTOME_DISEASES_OF_GLYCOSYLATION	0.380	-0.608	-0.330	-0.453	-1.317	-3.125	-1.034	0.660	0.509	2.032	2.669
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-0.471	-1.259	-0.471	-0.270	0.814	-2.031	-1.259	0.546	0.814	-0.270	3.498
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING	-0.507	-1.649	-1.261	-1.649	-0.507	-0.357	-0.507	1.363	0.368	1.109	3.866
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	0.440	-1.783	-0.810	0.275	-1.783	0.275	-0.527	0.275	-0.329	0.440	5.001
HUANG_FOXA2_TARGETS_UP HUANG_FOXA2_TARGETS_UP	-0.729	0.883	-0.431	-0.431	-0.242	-1.948	-1.948	-0.431	1.620	0.597	2.071
WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING	-1.118	-1.118	-0.260	0.644	-0.550	-0.260	-0.260	-0.550	2.675	-1.118	2.056
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	0.301	-0.957	-0.671	-1.335	-0.457	-0.457	-0.957	-0.457	-0.301	1.403	5.406
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	0.390	-1.966	-1.966	0.256	-0.351	0.390	-1.966	0.390	0.759	0.759	3.086
AMIT_SERUM_RESPONSE_60_MCF10A AMIT_SERUM_RESPONSE_60_MCF10A	-1.571	-0.668	-0.247	-1.035	-0.668	-1.571	-0.247	-0.247	1.456	1.112	3.264
NABA_BASEMENT_MEMBRANES NABA_BASEMENT_MEMBRANES	0.820	-0.958	-0.549	-0.300	-1.658	-0.549	-0.958	-0.300	0.527	0.302	4.501
PID_INTEGRIN4_PATHWAY PID_INTEGRIN4_PATHWAY	1.148	-0.455	-0.455	-0.455	-0.455	-0.455	-0.455	-0.455	0.578	-0.455	3.765
KERLEY_RESPONSE_TO_CISPLATIN_UP KERLEY_RESPONSE_TO_CISPLATIN_UP	-1.865	-0.392	-0.392	-1.124	-0.676	-1.124	0.226	0.409	0.654	1.320	3.294
REACTOME_DECTIN_2_FAMILY REACTOME_DECTIN_2_FAMILY	-0.241	-1.077	-1.077	-0.520	-0.241	-1.077	-0.520	0.371	-0.241	2.148	2.796
ROSS_AML_WITH_CBFB_MYH11_FUSION ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.864	0.476	-1.362	-1.362	-0.316	-1.362	-0.864	1.017	0.476	1.365	2.696
DOANE_BREAST_CANCER_ESR1_UP DOANE_BREAST_CANCER_ESR1_UP	0.702	-1.621	-1.621	0.380	-0.929	-1.237	-0.929	0.905	0.702	0.527	3.495
PID_P53_DOWNSTREAM_PATHWAY PID_P53_DOWNSTREAM_PATHWAY	-0.395	0.745	-0.718	-2.395	-0.283	-2.961	0.439	1.145	-0.395	0.933	2.222
LEE_LIVER_CANCER_CIPROFIBRATE_UP LEE_LIVER_CANCER_CIPROFIBRATE_UP	-0.452	-1.093	-1.093	-1.641	0.519	-0.273	-0.452	-0.452	-0.452	2.607	3.106
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	-0.301	-1.099	-1.361	-1.361	-0.301	-2.025	-0.405	0.661	1.406	1.406	2.762
CORRE_MULTIPLE_MYELOMA_UP CORRE_MULTIPLE_MYELOMA_UP	-0.577	-0.577	-1.198	-0.577	-1.198	-0.577	-0.842	-0.577	2.753	1.596	2.341
WESTON_VEGFA_TARGETS_6HR WESTON_VEGFA_TARGETS_6HR	1.512	-1.259	0.334	-0.471	-0.471	-0.782	-0.782	-0.782	-1.259	1.512	2.935
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.421	-0.421	-0.960	-0.960	-0.647	-0.960	-0.960	2.012	1.297	-0.647	3.361
GILDEA_METASTASIS GILDEA_METASTASIS	-0.300	-0.610	-1.201	-0.300	-1.201	-0.300	-0.300	-0.610	0.572	0.572	4.606
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	0.292	-2.006	-2.006	-0.430	-0.430	-0.311	-0.767	-0.311	0.693	1.298	3.869
WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY	-0.222	-0.491	-0.491	-0.222	-0.491	-1.036	-0.491	-0.222	-0.491	-0.222	6.291
CUI_TCF21_TARGETS_UP CUI_TCF21_TARGETS_UP	-0.234	-1.492	-1.492	-0.453	-0.453	-0.234	-0.453	-0.234	0.380	0.646	4.321
RASHI_RESPONSE_TO_IONIZING_RADIATION_1 RASHI_RESPONSE_TO_IONIZING_RADIATION_1	-0.525	0.320	0.320	-1.616	0.555	-0.925	-1.616	1.226	0.320	-0.525	2.693
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	-0.470	-1.677	-0.738	1.325	-1.677	0.498	-0.738	0.316	-0.738	1.325	2.546
LIANG_SILENCED_BY_METHYLATION_UP LIANG_SILENCED_BY_METHYLATION_UP	-0.385	-1.367	-1.367	0.231	-0.385	0.453	0.231	-1.367	0.453	1.130	2.674
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	-1.173	-1.474	0.310	-1.173	-0.402	-0.921	-0.292	-0.402	0.554	1.300	4.596
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-1.152	-0.301	-1.152	-1.152	-0.301	-1.152	-0.762	0.301	2.038	1.284	2.480
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	-0.925	-1.616	-1.616	1.656	0.320	-0.283	-0.525	-0.283	-0.283	0.858	2.148
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	-1.201	0.572	-1.201	-0.610	-0.610	-0.610	-0.610	0.572	1.877	-0.300	2.464
WP_NETRINUNC5B_SIGNALING_PATHWAY WP_NETRINUNC5B_SIGNALING_PATHWAY	-1.362	-0.316	-2.155	0.286	0.476	-0.864	-0.316	2.203	0.286	-0.534	2.208
SERVITJA_LIVER_HNF1A_TARGETS_DN SERVITJA_LIVER_HNF1A_TARGETS_DN	-0.594	-0.337	-2.714	-0.337	-0.452	1.354	-0.594	-1.511	0.480	0.771	3.387
AMIT_SERUM_RESPONSE_40_MCF10A AMIT_SERUM_RESPONSE_40_MCF10A	-0.733	0.231	-1.367	-0.385	-0.385	-1.367	-0.733	1.578	0.754	0.231	2.674
SEKI_INFLAMMATORY_RESPONSE_LPS_UP SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.383	-1.198	-0.842	-0.383	-0.383	-1.198	-1.198	0.367	0.367	1.596	4.198
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	0.555	-1.616	-1.616	1.226	-0.283	0.320	-0.925	-0.925	0.320	0.555	2.148
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	0.279	-0.324	-0.787	-0.787	-0.787	-0.787	-0.787	0.609	0.279	1.613	2.272
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	-1.501	-0.622	-1.501	-0.622	0.233	-0.977	0.233	0.612	0.612	0.612	4.000
ZHAN_MULTIPLE_MYELOMA_LB_UP ZHAN_MULTIPLE_MYELOMA_LB_UP	-0.431	-1.191	-1.191	-0.729	-0.431	-1.191	0.597	0.883	0.883	-0.431	3.695
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	0.612	-0.622	-1.501	-0.382	-2.321	0.397	0.233	-0.622	0.233	1.551	2.411
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION	-0.676	-0.392	-1.124	-0.676	0.226	-0.392	-1.865	0.226	0.654	1.320	3.294
SMID_BREAST_CANCER_LUMINAL_B_UP SMID_BREAST_CANCER_LUMINAL_B_UP	-0.346	0.355	-1.533	-1.533	-0.346	-1.240	-0.992	0.601	0.754	0.754	4.073
ZHAN_MULTIPLE_MYELOMA_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD2_UP	-0.451	-0.451	-0.755	-1.225	0.351	-1.225	-1.225	0.351	0.351	3.014	2.005
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	-0.580	0.324	-1.160	-1.160	-0.580	-0.580	0.324	1.432	0.324	-0.580	3.240
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	-0.676	-0.392	-0.676	-0.392	-1.124	-1.865	0.409	-0.392	1.736	0.654	2.728
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	0.680	-1.450	-0.796	-0.219	-0.219	-0.219	-0.796	0.403	-0.430	-0.796	4.460
WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	-0.882	-1.346	-1.346	0.932	0.285	-0.318	-1.636	0.932	0.491	-0.421	3.894
REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS	-0.324	0.279	-0.324	-0.787	-0.787	-0.787	-0.324	-0.324	-0.324	0.609	4.787
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	0.612	0.233	-0.382	-0.977	-1.501	-1.501	-0.622	-0.622	1.551	0.612	2.901
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	-0.324	0.279	-0.787	-0.787	-0.787	1.613	-0.787	-0.324	-0.324	0.279	3.022
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	0.381	-2.289	-1.171	-0.819	-0.368	-0.819	-0.559	1.313	0.772	0.558	2.820
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	-0.301	0.301	-0.301	-1.152	-1.712	-1.712	-0.762	0.478	1.640	0.970	2.043
EHRLICH_ICF_SYNDROM_DN EHRLICH_ICF_SYNDROM_DN	-0.704	-0.272	-0.272	-0.704	0.706	-0.272	0.332	-0.704	-0.704	-0.272	4.282
CHEBOTAEV_GR_TARGETS_UP CHEBOTAEV_GR_TARGETS_UP	1.025	-1.171	0.243	-1.643	-1.171	-1.643	-0.368	0.558	0.558	1.025	2.395
KEGG_GRAFT_VERSUS_HOST_DISEASE KEGG_GRAFT_VERSUS_HOST_DISEASE	-0.477	-1.533	-0.860	-0.477	-0.860	-0.250	-0.250	-0.250	-0.250	2.876	2.308
LOPES_METHYLATED_IN_COLON_CANCER_UP LOPES_METHYLATED_IN_COLON_CANCER_UP	0.607	-0.580	-1.160	-0.580	0.324	-0.580	0.324	-1.160	0.978	-0.580	3.240
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY WP_GLUCOCORTICOID_RECEPTOR_PATHWAY	-0.276	-0.986	0.328	-0.986	-0.986	0.328	-2.034	0.712	0.328	0.500	3.794
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	0.371	-1.077	-0.520	-1.077	-1.077	-0.241	-0.241	-0.241	-0.241	2.148	2.152
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.228	-1.906	-1.906	-0.411	-0.228	-0.228	-0.702	0.920	0.625	0.625	2.139
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	0.167	-0.497	-0.497	1.052	-0.497	-0.497	-0.497	-0.497	-0.497	1.052	2.550
KANG_IMMORTALIZED_BY_TERT_DN KANG_IMMORTALIZED_BY_TERT_DN	-1.028	-2.398	0.687	-0.250	-0.537	-0.752	-1.028	-0.250	1.136	0.896	2.768
PID_INTEGRIN1_PATHWAY PID_INTEGRIN1_PATHWAY	0.604	-1.271	-1.271	-1.271	-0.566	0.250	-0.859	0.405	0.846	0.405	3.672
GHANDHI_DIRECT_IRRADIATION_UP GHANDHI_DIRECT_IRRADIATION_UP	-0.601	-0.424	-0.601	-0.424	-0.424	-0.291	-2.534	-0.829	1.559	1.027	2.953
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	0.337	-0.833	-1.563	-1.563	0.337	0.337	-1.151	0.672	1.138	-0.404	3.280
HINATA_NFKB_TARGETS_FIBROBLAST_UP HINATA_NFKB_TARGETS_FIBROBLAST_UP	-0.911	-0.633	-0.277	-0.633	-1.280	-0.911	-0.911	0.910	0.910	0.484	3.964
AMIT_SERUM_RESPONSE_240_MCF10A AMIT_SERUM_RESPONSE_240_MCF10A	-2.363	-0.235	-0.645	-0.645	-0.645	-0.645	-0.235	0.379	1.503	0.379	2.826
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	-0.271	-2.225	-0.755	-0.552	-0.552	-0.393	-1.013	-0.271	1.543	0.816	3.270
KANG_IMMORTALIZED_BY_TERT_UP KANG_IMMORTALIZED_BY_TERT_UP	-1.053	-0.351	-1.448	-0.521	0.995	-0.751	-0.521	1.566	-1.448	0.995	2.269
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-0.489	-1.152	-0.301	-0.762	-0.762	-1.712	0.970	-0.489	0.478	1.284	2.956
KEGG_ARACHIDONIC_ACID_METABOLISM KEGG_ARACHIDONIC_ACID_METABOLISM	0.346	-0.434	-0.691	-0.260	-2.446	-0.260	-1.064	-0.434	0.784	1.075	2.682
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	0.850	-2.180	-1.548	-0.753	0.276	-0.327	-0.505	-0.327	0.428	0.850	3.011
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.411	-1.157	-1.157	-0.411	-0.411	0.389	-0.702	-1.157	0.920	2.134	2.139
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	-2.238	-0.348	-0.348	-0.578	-0.348	-0.578	0.258	-0.348	1.275	-0.348	3.609
LE_NEURONAL_DIFFERENTIATION_UP LE_NEURONAL_DIFFERENTIATION_UP	-0.298	-0.745	-0.745	-0.298	-0.745	-0.298	-0.298	1.128	-0.745	1.128	2.403
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	0.566	-0.828	-0.828	-0.828	-0.351	1.521	-0.351	0.256	0.256	-0.828	2.152
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.651	-0.889	-0.323	-0.889	0.405	-2.636	-0.465	0.405	2.072	0.559	2.079
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.312	-0.869	-1.540	-0.634	-0.869	0.290	-0.869	-0.634	1.491	2.114	2.120
WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS	-0.324	-0.787	-0.787	-0.324	-0.787	1.057	-0.787	-0.324	0.279	1.057	2.272
BIOCARTA_CTL_PATHWAY BIOCARTA_CTL_PATHWAY	-0.538	-0.538	-0.538	-0.538	-0.538	-0.538	-0.176	1.603	0.476	-0.176	2.373
AGARWAL_AKT_PATHWAY_TARGETS AGARWAL_AKT_PATHWAY_TARGETS	-0.455	-0.455	-0.455	1.148	-0.455	-0.455	0.187	0.578	-0.455	-0.455	2.751
AUJLA_IL22_AND_IL17A_SIGNALING AUJLA_IL22_AND_IL17A_SIGNALING	-0.455	-0.455	-0.455	1.148	0.187	-0.455	-0.455	-0.455	-0.455	0.578	2.751
KIM_MYCL1_AMPLIFICATION_TARGETS_UP KIM_MYCL1_AMPLIFICATION_TARGETS_UP	-0.199	-0.580	-0.199	-0.580	-0.199	-0.199	-0.580	-0.580	-0.580	2.211	2.214
HAHTOLA_CTCL_PATHOGENESIS HAHTOLA_CTCL_PATHOGENESIS	-0.223	-0.621	-0.621	-0.621	-0.621	-0.223	-0.621	-0.223	0.823	0.823	2.869
SHIN_B_CELL_LYMPHOMA_CLUSTER_6 SHIN_B_CELL_LYMPHOMA_CLUSTER_6	-0.497	-0.497	-0.497	-0.497	0.167	0.524	-0.497	-0.497	0.167	0.524	3.499
